9265

繝、繝槭す繧ソ繝倥Ν繧ケ繧ア繧「繝帙�シ繝ォ繝�繧」繝ウ繧ー繧ケ譬ェ蠑丈シ夂、セ

ヤマシタヘルスケアホールディングス株式会社
Wholesale Trade
Yamashita Health Care Holdings,Inc. engages in the supply of medical equipment in Japan. The company offers diagnostic imaging devices, such as MRI and CT, endoscopic systems, operating tables, and surgical equipment comprising electric scalpels, orthopedic implants, various catheters, and disposable medical materials; plans, outsources, manufactures, consigns, imports, and sells implants that are embedded in the body in the field of orthopedics; and sells and maintains medical equipment, which include dialysis machines/dialysis consumables, peritoneal dialysis, lithotripsy, and stents. It also provides consulting services related to the construction of nursing care facilities, M&A, and support to medical and nursing care institutions; and develops reservation solutions for hospitals consisting of search portal sites for hospitals and clinics, online reservations, posting agency for customer satisfaction surveys, and network security systems sales. In addition, the company offers network integration and software design and development; equipment used in physical therapy and rehabilitation, as well as related consumables such as surgical gowns, gloves, and bandages; manufactures and sells medical devices, and conduct contract research on medical ultrasound, as well as the development, sales, and consulting of medical devices and peripheral devices that use ultrasound. Yamashita Health Care Holdings,Inc. was founded in 1926 and is based in Fukuoka City, Japan.
← Companies
Price
¥3,065
Market Cap
¥7.6B
Ent. Value
Net Cash est
Shares Out.
2.5M
P / E
12.3×
EV / EBIT
P / Book
0.84×
P / NCAV
2.36×
Div. Yield
2.45%
Financials
Metric FY 2025
EDINET ↗
FY 2024
EDINET ↗
FY 2023
EDINET ↗
FY 2022
EDINET ↗
FY 2021
EDINET ↗
Net Sales ¥64.5B ¥61.6B ¥58.2B ¥55.1B ¥70.1B
Cost of Sales ¥55.7B ¥53.1B ¥50.1B ¥47.4B ¥62.6B
Gross Profit ¥8.8B ¥8.5B ¥8.0B ¥7.7B ¥7.5B
SG&A ¥7.9B ¥7.5B ¥6.9B ¥6.8B ¥6.5B
Operating Income ¥838M ¥967M ¥1.2B ¥931M ¥969M
Non-Operating Income ¥96M ¥79M ¥71M ¥86M ¥73M
Dividend Income ¥8M ¥6M
Interest Income ¥2M ¥2M
Non-Operating Expenses ¥25M ¥26M ¥20M ¥13M ¥15M
Interest Expense ¥6M ¥0M ¥2M ¥4M ¥4M
Ordinary Income ¥909M ¥1.0B ¥1.2B ¥1.0B ¥1.0B
Pre-tax Income ¥943M ¥871M ¥635M ¥1.0B ¥1.1B
Income Taxes ¥329M ¥293M ¥423M ¥330M ¥373M
Current Tax ¥379M ¥378M ¥442M ¥285M ¥358M
Deferred Tax ¥-49M ¥-84M ¥-18M ¥45M ¥15M
Net Income (owners) ¥616M ¥580M ¥219M ¥696M ¥678M
Minority Interest ¥-2M ¥-3M ¥-7M ¥-1M
Comprehensive Income ¥671M ¥920M ¥128M ¥630M ¥779M
EBITDA ¥1.1B ¥1.2B ¥1.4B ¥1.2B ¥1.2B
Goodwill Amort. (J-GAAP) ¥45M ¥28M ¥14M ¥22M ¥14M
EPS ¥249.79 ¥227.96 ¥85.83 ¥272.67 ¥265.77
Shares Outstanding 2.5M 2.5M 2.6M 2.6M 2.6M
Shares Issued (total) 2.6M 2.6M 2.6M 2.6M 2.6M
Treasury Shares 0.1M 0.1M 0.0M 0.0M 0.0M